HSIC - Why Is Dental Supplier Henry Schein Stock Trading Higher Today? | Benzinga

Henry Schein Inc (NASDAQ: HSIC) reported Q3 FY23 sales of $3.16 billion, slightly missing the consensus of $3.21 billion, up 3.1% Y/Y, including a 1.2% decrease in local currencies excluding acquisitions, reflecting some market softening in the second half of the quarter as well as lower sales of PPE products and COVID-19 test kits.

Growth from acquisitions was 3.2%, and a 1.1% increase in net sales related to foreign currency exchange. 

Sales of PPE products and COVID-19 test kits in the quarter were $175 million, a decrease of $69 million versus the prior-year period. 

Also Read: Full story available on Benzinga.com